| 1781 |
|
Advances in Brief - Estrogens Do Not Modify MAP Kinase-dependent Nuclear Signaling during Stimulation of Early G1 Progression in Human Breast Cancer Cells./
|
Caristi, Silvana
|
Williams and Wilkins
|
2001
|
|
|
|
| 1782 |
|
Advances in Brief - Evidence Supporting a Role for Mitochondrial Respiration in Apoptosis Induction by the Synthetic Retinoid CD437./
|
Hail Jr, Numsen
|
Williams and Wilkins
|
2001
|
|
|
|
| 1783 |
|
Advances in Brief - Evidence That APC Regulates Survivin Expression: A Possible Mechanism Contributing to the Stem Cell Origin of Colon Cancer./
|
Zhang, Tao
|
Williams and Wilkins
|
2001
|
|
|
|
| 1784 |
|
Advances in Brief - Experimental Therapeutics, Preclinical Pharmacology - Adriamycin Sensitizes the Adriamycin-resistant 8226/Dox40 Human Multiple Myeloma Cells to Apo2L/Tumor Necrosis Factor-related Apoptosis-inducing Ligand-mediated (TRAIL) Apoptosis./
|
Jazirehi, Ali R
|
The Association
|
2001
|
|
|
|
| 1785 |
|
Advances in Brief - Experimental Therapeutics, Preclinical Pharmacology - A Selective Cyclooxygenase-2 Inhibitor, NS-398, Enhances the Effect of Radiation in Vitro and in Vivo Preferentially on the Cells That Express Cyclooxygenase-2./
|
Pyo, Hongryull
|
The Association
|
2001
|
|
|
|
| 1786 |
|
Advances in Brief - Experimental Therapeutics, Preclinical Pharmacology - Characterization of HLA-A3-restricted Cytotoxic T Lymphocytes Reactive against the Widely Expressed Tumor Antigen Telomerase./
|
Vonderheide, Robert H
|
The Association
|
2001
|
|
|
|
| 1787 |
|
Advances in Brief - Experimental Therapeutics, Preclinical Pharmacology - Effects of Signal Transduction Inhibitor 571 in Acute Myelogenous Leukemia Cells./
|
Scappini, Barbara
|
The Association
|
2001
|
|
|
|
| 1788 |
|
Advances in Brief - Experimental Therapeutics, Preclinical Pharmacology - Induction of Apoptosis of Integrin-expressing Human Prostate Cancer Cells by Cyclic Arg-Gly-Asp Peptides./
|
Chatterjec, Subhendra
|
The Association
|
2001
|
|
|
|
| 1789 |
|
Advances in Brief - Experimental Therapeutics, Preclinical Pharmacology - Induction of Topoisomerase II Activity after ErbB2 Activation Is Associated with a Differential Response to Breast Cancer Chemotherapy./
|
Harris, L N
|
The Association
|
2001
|
|
|
|
| 1790 |
|
Advances in Brief - Experimental Therapeutics, Preclinical Pharmacology - Modulation of Hsp90 Function by Ansamycins Sensitizes Breast Cancer Cells to Chemotherapy-induced Apoptosis in an RB- and Schedule-dependent Manner. See The Biology Behind: E. A. Sausville, Combining Cytotoxics and 17-Allylamino, 17-Demethoxygeldanamyci: Sequence and Tumor Biology Matters. Clin. Cancer Res., 7: 2155-2158, 2001./
|
M�nster, Pamela N
|
The Association
|
2001
|
|
|
|
| 1791 |
|
Advances in Brief - Experimental Therapeutics, Preclinical Pharmacology - Paclitaxel and Docetaxel Enhance the Metabolism of Doxorubicin to Toxic Species in Human Myocardium./
|
Minotti, Giorgio
|
The Association
|
2001
|
|
|
|
| 1792 |
|
Advances in Brief - Experimental Therapeutics, Preclinical Pharmacology - Pan-trk Inhibition Decreases Metastasis and Enhances Host Survival in Experimental Models as a Result of Its Selective Induction of Apoptosis of Prostate Cancer Cells./
|
Weeraratna, Ashani T
|
The Association
|
2001
|
|
|
|
| 1793 |
|
Advances in Brief - Experimental Therapeutics, Preclinical Pharmacology - Protein Binding Alters the Activity of Suramin, Carboxyamidotriazole, and UCN-01 in an ex Vivo Rat Aortic Ring Angiogenesis Assay./
|
Kr�ger, Erwin A
|
The Association
|
2001
|
|
|
|
| 1794 |
|
Advances in Brief - Experimental Therapeutics, Preclinical Pharmacology - Thalidomide and Its Analogues Inhibit Lipopolysaccharide-mediated Induction of Cyclooxygenase-2./
|
Fujita, Junya
|
The Association
|
2001
|
|
|
|
| 1795 |
|
Advances in Brief - Experimental Therapeutics, Preclinical Pharmacology - The Investigational New Drug XK469 Induces G2-M Cell Cycle Arrest by p53-dependent and -independent Pathways./
|
Ding, Zhenhua
|
The Association
|
2001
|
|
|
|
| 1796 |
|
Advances in Brief - Experimental Therapeutics, Preclinical Pharmacology - Therapy of Disseminated B-Cell Lymphoma Xenografts in Severe Combined Immunodeficient Mice with an Anti-CD74 Antibody Conjugated with 111Indium, 67Gallium, or 90Yttrium./
|
Ochakovskaya, Rita
|
The Association
|
2001
|
|
|
|
| 1797 |
|
Advances in Brief - Expression of the Invasion Factor Laminin g2 in Colorectal Carcinomas Is Regulated by b-Catenin./
|
Hlubek, Falk
|
Williams and Wilkins
|
2001
|
|
|
|
| 1798 |
|
Advances in Brief - Expression Profiling Reveals Hepsin Overexpression in Prostate Cancer./
|
Magee, Jeffrey A
|
Williams and Wilkins
|
2001
|
|
|
|
| 1799 |
|
Advances in Brief - Extraction of 5-Fluorouracil by Tumor and Liver: A Noninvasive Positron Emission Tomography Study of Patients with Gastrointestinal Cancer./
|
Aboagye, Eric O
|
Williams and Wilkins
|
2001
|
|
|
|
| 1800 |
|
Advances in Brief - Fluorescent Methylation-specific Polymerase Chain Reaction for DNA-based Detection of Prostate Cancer in Bodily Fluids./
|
Goessl, Carsten
|
Williams and Wilkins
|
2001
|
|
|
|